Investor Presentaiton

3 We can tap into our 380+ Oncology, and, over time, Screening commercial teams to efficiently commercialize MRD ASP Reimbursement-gated Volume Trajectory CRC surveillance Volume 7 800 Lung Breast GUARDANT™ INVESTOR 20 DAY 23 70

View entire presentation